To access this element change to forms mode OFF
Grant Award View - GA294522
Novel therapeutic strategies to intervene in tau-associated...
GA ID:
GA294522
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
13-Feb-2023
Publish Date:
11-Apr-2023
Category:
Medical Research
Grant Term:
1-Apr-2023 to 31-Mar-2026
Value (AUD):
$499,644.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 21/22 1.1 Health and Medical Research
Grant Program:
International Joint Calls
Grant Activity:
Novel therapeutic strategies to intervene in tau-associated neurodegeneration by modulating tau clearance and neuroinflammation
Purpose:
Research has shown that abnormal build-up of tau protein triggers neuron death and the onset of dementia. Investigators in this project will develop the rationale to link pathways that contribute to dangerous levels of tau protein trash and examine if our candidate therapeutics can block these damaging cascades and thus delay the progression of dementia. A positive outcome for this study will be to identify specific and effective therapies to transition to a phase 1 clinical trial for dementia.
GO ID:
GO Title:
NHMRC-AMED 2022 Dementia Collaborative Research Scheme funding commencing in 2022
Internal Reference ID:
2023/GNT2022535
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC, Overseas
Postcode:
Multiple
Country:
AUSTRALIA, JAPAN